Page last updated: 2024-11-04

terfenadine and Cancer of Head

terfenadine has been researched along with Cancer of Head in 2 studies

Terfenadine: A selective histamine H1-receptor antagonist devoid of central nervous system depressant activity. The drug was used for ALLERGY but withdrawn due to causing LONG QT SYNDROME.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Dannhorn, A1
Ling, S1
Powell, S1
McCall, E1
Maglennon, G1
Jones, GN1
Pierce, AJ1
Strittmatter, N1
Hamm, G1
Barry, ST1
Bunch, J1
Goodwin, RJA1
Takats, Z1
Codreanu, I1
Dasanu, CA1
Weinstein, GS1
Divgi, C1

Other Studies

2 other studies available for terfenadine and Cancer of Head

ArticleYear
Evaluation of UV-C Decontamination of Clinical Tissue Sections for Spatially Resolved Analysis by Mass Spectrometry Imaging (MSI).
    Analytical chemistry, 2021, 02-09, Volume: 93, Issue:5

    Topics: Animals; Azetidines; COVID-19; Decontamination; Head and Neck Neoplasms; Humans; Male; Metabolome; N

2021
Fluorodeoxyglucose-induced allergic reaction: a case report.
    Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners, 2013, Volume: 19, Issue:1

    Topics: Anti-Allergic Agents; Anti-Inflammatory Agents; Carcinoma, Squamous Cell; Diphenhydramine; Drug Hype

2013